Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effects of chloroquine on blood glutathione S-transferases M1 and A

Clinica Chimica Acta

Volumn 265, Issue 2, 1997, Pages 145-155

  Mukanganyama, Stanley ^a   Masimirembwa, Collen M ^a   Naik, Yogeshkumar S ^a   Hasler, Julia A ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Black Zimbabweans; Chloroquine; Glutathione S transferases; Phenotype

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; GLUTATHIONE TRANSFERASE; ISOENZYME;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTERMETHOD COMPARISON; MUTATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ZIMBABWE;

ANTIMALARIALS; CHLOROQUINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0030807460     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00104-6     Document Type: Article

References (28)

1. Hayes DJ, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
2. Mannervik B. The isoenzymes of glutathione transferases. Adv Enzymol Relat Areas Mol Biol 1985;57:357-417.
3. Mannervik B, Awasthi YC, Board PG et al. Nomenclature of human glutathione transferases. Biochem J 1992;282:305-6.
4. Beckett GJ, Hayes JD. Glutathione S-transferases: Biomedical applications. Adv Clin Chem 1993;30:281-380.
5. Singhal SS, Saxena M, Ahmad H, Awasthi S, Haque AK, Awasthi YC. Glutathione S-transferases of human lung: characterisation and evaluation of the protective role of the α-class isoenzymes against lipid peroxidation. Arch Biochem Biophys 1992;299:232-41.
6. van Ommen B, Bogaards JJP, Peters WHM, Blauber B, van Bladeren PJ. Quantification of human hepatic glutathione S-transferases. Biochem J 1990;269:609-13.
7. Trull AK, Facey SP, Rees GW et al. Serum α-glutathione S-transferase-a sensitive marker of hepatocellular damage associated with acute liver allograft rejection. Transplantation 1994;58:13451351.
8. Nelson DR, Lim HL, Oliver D, Qian K, Davis GL, Lau JYN. α-Glutathione S-transferase as a marker of hepatocellular damage in chronic hepatitis C virus infection. Am J Clin Pathol 1995;104:193-8.
9. Board PG, Coggan M, Johnston P, Ross V, Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther 1990;48:357-69.
10. Seidegård J, Varachek RW, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988;85:7293-7.
11. Board PG, Johnston NP, Ross VL, Webb CG, Coggan M, Suzuki T. Molecular genetics of the Human Glutathione S-transferase. In: Ernster et al., editors. Xenobiotics and Cancer. Tokyo: Japan Scientific Society Press. 1991:199-211.
12. Seidegård J, Pero RW, Marowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: A follow up study. Carcinogenesis (London) 1990;11:33-6.
13. Slone DH, Gallagher EP, Ramsdell HS et al. Human variability in hepatic glutathione S-transferase mediated conjugation of aflatoxin B1-epoxide and other substrates. Pharmacogenetics 1995;5:224-33.
14. McGlynn KA, Rosvold EA, Lustbader ED et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 1995;92:2384-7.
15. Back JD, Purba HS, Saeger C, Ornh LE, Breckenridge AM. Inhibition of drug metabolism by the antimalarial drug chloroquine and primaquine in the rat. Biochem Pharmacol 1983;32:257-63.
16. Brockmöller J, Gross D, Kerb R, Drakoulis N, Roots I. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class Mu gene detected by the polymerase chain reaction. Biochem Pharmacol 1992;43:647-50.
17. Zhao L, Alldersea J, Fryer A et al. Polymorphism of the glutathione S-transferase GSTM1 locus: a study of the frequencies of the GSTM1 A,B,A/B and null phenotype in Nigerians. Clinica Chimica Acta 1994;225:85-8.
18. Strange RC. Glutathione S-transferase and cancer susceptibility. In: Vermeulen NPE, Mulder GJ, Nieuwenhuyse H. et al., editors. Glutathione S-transferases structure, function and clinical implications. London: Taylor and Francis. 1996:239247.
19. Lee EJD, Zhao B, Moochhala SM, Ngoi SS. Frequency of mutant CYP1Al, NAT2, and GST M1 alleles in a normal Chinese population. Pharmacogenetics 1994;4:355-8.
20. Brockmöller J, Kerb R, Drakooulis N, Nitz M, Roots I. Genotype and phenotype of glutathíone SO-transferase class μ isoenzymes μ and φ in lung cancer patients and controls. Cancer Res 1993;53:1004-11.
21. Pussard E, Verdier F. Antimalarial aminoquinolines; mode of action and pharmacokinetics. Fundament Clin Pharmacol 1994;8:1-17.
22. Wernsdorfer WH, McGregor SI. Principles and practice of Malariology. London: Churchill Livingstone, 1988.
23. Seglen PO. Inhibitors of lysosomal function. Methods Enzymol 1983;96:288-94.
24. Roskoski Jr. J, Jaskunas SR. Chloroquine and primaquine inhibition of rat cell-free polynucleotide-dependant polypeptide synthesis. Biochem Pharmacol 1972;21:391-9.
25. Emerole GO, Thabrew MI. Changes in some rat hepatic microsomal components induced by prolonged administration of chloroquine. Biochem Pharmacol 1983;32:3005-9.
26. Nakagawa K. Relationship between glutathione content and formation of organic solvent soluble fluorescent pigments in mice treated with chloroquine. Toxicol 1991;66:165-73.
27. Magwere T, Naik YS, Hasler JA. Effects of chloroquine treatment on antioxidant enzymes in rat liver and kidney. Free Radical Biol Med 1997;22:321-7.
28. Zhu X, Ertel W, Ayala M, Morrison MH, Perrin MM, Chaundry IH. Chloroquine inhibits macrophage necrosis factor-alpha mRNA transcription. Immunol 1993;80:122-6.